Activity and protein levels of ALDH2 shown to mediate the oxidation of acetaldehyde to acetate [24] were similar in livers of MASLD patients and controls (Figs. S1A and B). This evidence concerns the gene ALDH2 and metabolic dysfunction-associated steatotic liver disease.